E De Clercq - Annual Review of Pharmacology and Toxicology, 2011 - annualreviews.org My search for a selective antiviral chemotherapy started more than 40 years ago with interferon inducers, then shifted to nucleoside analogs with the discovery of BVDU (brivudin), a highly selective anti-HSV-1 and anti-VZV agent, and to dideoxynucleoside analogs such as d4T ... Related articles
FR Slater, AC Singer, S Turner… - FEMS microbiology …, 2011 - Wiley Online Library ... adaptation of activated sludge bacteria to degrade the antiviraldrug Oseltamivir (Tamiflu) and loss of nutrient removal performance ... References Accinelli, C., Caracciolo, AB and Grenni, P. (2007) Degradation of the antiviraldrug oseltamivir carboxylate in surface water samples. ... Cited by 2 - Related articles - All 6 versions
E De Clercq - Medicinal Research Reviews, 2011 - Wiley Online Library This review article corresponds to the fifth paper in the series of stories on antiviral drug discovery (part E), thus following up, in a similar, narrative style on the stories presented in part A (although, it was not labeled as such),1 part B,2 part C,3 and part D.4 The present article ( ... Cited by 11 - Related articles - All 2 versions
[HTML] from cdc.govCY Atkins, A Patel, TH Taylor Jr… - Emerging infectious …, 2011 - cdc.gov Abstract From April 2009 through March 2010, during the pandemic (H1N1) 2009 outbreak, ≈8.2 million prescriptions for influenza neuraminidase-inhibiting antiviral drugs were filled in the United States. We estimated the number of hospitalizations likely averted due to use ... Cached
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
